USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$39.50 USD
+0.10 (0.25%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $39.46 -0.04 (-0.10%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
Brokerage Reports
0 items in cart
USANA Health Sciences, Inc. [USNA]
Reports for Purchase
Showing records 21 - 40 ( 129 total )
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 101123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Maintain $74 Target Based On Expected 2024 Sales, EPS Rebound, Solid Balance Sheet, Ample Free Cash Flow Prospects
Provider: Sidoti CSR
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
3Q:23 Was Likely Impacted By An Uneven Post-Covid China Recovery
Provider: Sidoti CSR
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 82123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
2Q:23 Revenue, EPS Topped Our Forecasts,Increase EPS Estimates As USNA Raises Guidance
Provider: Sidoti CSR
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
2Q:23 Hurt By Lower Sales, Margin Pressure, In Our View; Still Expect 20% EPS Rise In 2024 Driven By Better Macroeconomy, Rebound In China, Entry To India; Maintain $72 Price Target
Provider: Sidoti CSR
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Initiate Coverage Of USANA Health Sciences, Inc. (USNA) With A $72 Price Target
Provider: Sidoti CSR
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for USNA 3123
Provider: Stock Traders Daily
Analyst: Research Department